Details for Patent: 8,642,079

Which drugs does patent 8,642,079 protect, and when does it expire?

Patent 8,642,079 protects OSPHENA and is included in one NDA.

This patent has twenty-four patent family members in eighteen countries.

Summary for Patent: 8,642,079

Title:	Solid formulations of ospemifene
Abstract:	This invention relates to a solid drug formulation comprising granulates containing a therapeutically active compound of the formula (I) ##STR00001## or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, in combination with one or more intra-granular excipients.
Inventor(s):	Lehtola; Veli-Matti (Turku, FI), Halonen; Kaija (Rusko, FI)
Assignee:	Hormos Medical Corporation (Turku, FI)
Application Number:	10/783,024
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,642,079
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound;

Drugs Protected by US Patent 8,642,079

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Duchesnay	OSPHENA	ospemifene	TABLET;ORAL	203505-001	Feb 26, 2013	AB	RX	Yes	Yes			Y

International Family Members for US Patent 8,642,079

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	E506054
Australia	2005215174
Brazil	PI0507897